Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC77H103ClN18O16 |
InChIKeySSKYEXNPDKMKLB-UHFFFAOYSA-N |
CAS Registry149716-24-5 |


| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Germany | - | |
| Neoplasms | Preclinical | - | - |






